Effective date
Medicare changes effective September 21, 2021
1 CMS and MAC policy update takes effect on this date. Every entry links to the government document it came from.
Fewer than 5 updates — this date is not listed in the index.
FDA · 1
- FDA Approval: OPZELURA (RUXOLITINIB) — Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated
FDA-NDA215309NationalDermatologysource ↗